Search

Displaying results 1471 - 1480 of 10000 in total
  1. Drug

    Aluminum hydroxide

    go.drugbank.com/drugs/DB06723
    ApprovedInvestigational

    Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects.

    Mixtures: O Hui Veil Fit Dual Foundation 20, O Hui Veil Fit Dual Foundation 30Products: ALU-TAB TABLET 600 MG, ACTAL TABLET 216 mg
  2. Drug

    Pegloticase

    go.drugbank.com/drugs/DB09208
    ApprovedInvestigational

    Pegloticase is a porcine recombinant PEGylated uricase indicated for the treatment of chronic gout in adult patients that do not respond to other types of therapies. … [A249980] However, cases of anaphylaxis and infusion reactions have been reported in patients treated with this drug.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Denosumab

    go.drugbank.com/drugs/DB06643
    ApprovedInvestigational

    [A263071] Chemically, it consists of 2 heavy and 2 light chains, with each light chain consisting of 215 amino acids and each heavy chain consisting of 448 amino acids with 4 intramolecular disulfides. … [A263066] Denosumab was approved by the FDA approved on June 2010 for the treatment of osteoporosis in postmenopausal women.

    Categories: Drugs for Treatment of Bone DiseasesProducts: XGEVA® 120 MG/1.7 ML, XGEVA Solution for Injection 120 mg/vial
  4. Drug

    Octyl triazone

    go.drugbank.com/drugs/DB15469
    Investigational

    Mixtures: SUN PROJECT SILKY CALMING SUN stick, Xoul 60days sun
  5. Drug

    Bentiromide

    go.drugbank.com/drugs/DB00522
    ApprovedWithdrawn

    Cases of headache and gastrointestinal disturbances have been reported with the use of bentiromide. Bentiromide is currently not available in the U.S. or Canada. … Bentiromide is a dipeptide that is used in the bentiromide test, which is a screening test for evaluating pancreatic exocrine function and monitoring the adequacy of supplemental pancreatic therapy.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Omacetaxine mepesuccinate

    go.drugbank.com/drugs/DB04865
    ApprovedInvestigationalWithdrawn

    used to treat accelerated or chronic phase CML. … Then in March 2006, it received Orphan Drug status from the FDA for the treatment of CML.

    Categories: Heterocyclic Compounds with 4 or More Rings
  7. Drug

    Menadione

    go.drugbank.com/drugs/DB00170
    ApprovedNutraceutical

    A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

    Mixtures: LIBAVIT-K 20 MG AMPUL, 5 ADETProducts: VITAMIN K 10 MG, VI-PLEX K 10 MG 3 AMPUL
  8. Drug

    Ferumoxides

    go.drugbank.com/drugs/DB09508
    Approved

    Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household setting
  9. Drug

    Meglumine

    go.drugbank.com/drugs/DB09415
    ApprovedInvestigational

    Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household setting
  10. Drug

    Dexfenfluramine

    go.drugbank.com/drugs/DB01191
    ApprovedIllicitWithdrawn

    However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn. … For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome